- Home
- TXMD vs WATT Comparison
TXMD vs WATT Comparison
Compare TXMD & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- WATT
- Stock Information
- Founded
- TXMD 2008
- WATT 2012
- Country
- TXMD United States
- WATT United States
- Employees
- TXMD N/A
- WATT N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- TXMD Health Care
- WATT Technology
- Exchange
- TXMD Nasdaq
- WATT Nasdaq
- Market Cap
- TXMD 12.8M
- WATT 14.9M
- IPO Year
- TXMD N/A
- WATT 2014
- Fundamental
- Price
- TXMD $1.06
- WATT $0.51
- Analyst Decision
- TXMD
- WATT Strong Buy
- Analyst Count
- TXMD 0
- WATT 2
- Target Price
- TXMD N/A
- WATT $2.25
- AVG Volume (30 Days)
- TXMD 852.1K
- WATT 18.3M
- Earning Date
- TXMD 11-12-2024
- WATT 11-12-2024
- Dividend Yield
- TXMD N/A
- WATT N/A
- EPS Growth
- TXMD N/A
- WATT N/A
- EPS
- TXMD N/A
- WATT N/A
- Revenue
- TXMD $1,596,000.00
- WATT $431,184.00
- Revenue This Year
- TXMD $605.07
- WATT $95.75
- Revenue Next Year
- TXMD $1.11
- WATT $834.07
- P/E Ratio
- TXMD N/A
- WATT N/A
- Revenue Growth
- TXMD N/A
- WATT N/A
- 52 Week Low
- TXMD $0.70
- WATT $0.28
- 52 Week High
- TXMD $2.75
- WATT $2.75
- Technical
- Relative Strength Index (RSI)
- TXMD 44.74
- WATT 46.88
- Support Level
- TXMD $0.99
- WATT $0.49
- Resistance Level
- TXMD $1.14
- WATT $1.44
- Average True Range (ATR)
- TXMD 0.27
- WATT 0.34
- MACD
- TXMD -0.00
- WATT -0.06
- Stochastic Oscillator
- TXMD 20.69
- WATT 5.81
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.